The global Assisted Reproductive Technologies Drugs market was valued at 12150 million in 2024 and is projected to reach US$ 19340 million by 2031, at a CAGR of 7.0% during the forecast period.
Assisted reproductive technology (ART) is used to treat infertility. It includes fertility treatments that handle both eggs and sperm. A number of different agents are used to achieve controlled ovarian hyperstimulation. These include clomiphene, GnRH analogues, menotropins, urofollitropin, highly purified FSH, and recombinant human FSH (rh-FSH), etc.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Assisted Reproductive Technologies Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Assisted Reproductive Technologies Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Assisted Reproductive Technologies Drugs. This report contains market size and forecasts of Assisted Reproductive Technologies Drugs in global, including the following market information:
Global Assisted Reproductive Technologies Drugs market revenue, 2020-2025, 2026-2031, ($ millions)
Global top five Assisted Reproductive Technologies Drugs companies in 2024 (%)
Total Market by Segment:
Global Assisted Reproductive Technologies Drugs market, by Type, 2020-2025, 2026-2031 ($ millions)
Global Assisted Reproductive Technologies Drugs market segment percentages, by Type, 2024 (%)
Down-Regulation Drugs
Ovulation Stimulation Drugs
Ovulation Inducing Drugs
Luteal Support Medications
Global Assisted Reproductive Technologies Drugs market, by Application, 2020-2025, 2026-2031 ($ millions)
Global Assisted Reproductive Technologies Drugs market segment percentages, by Application, 2024 (%)
Hospital Pharmacy
Specialty & Retail Pharmacy
Online Pharmacy
Global Assisted Reproductive Technologies Drugs market, by region and country, 2020-2025, 2026-2031 ($ millions)
Global Assisted Reproductive Technologies Drugs market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Assisted Reproductive Technologies Drugs revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Assisted Reproductive Technologies Drugs revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck Serono
Ipsen
Ferring
Organon
Solvay
Besins
Zhejiang Xianju
Changchun GeneScience
Hybio Pharmaceutical
Livzon Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Assisted Reproductive Technologies Drugs, market overview.
Chapter 2: Global Assisted Reproductive Technologies Drugs market size in revenue.
Chapter 3: Detailed analysis of Assisted Reproductive Technologies Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Assisted Reproductive Technologies Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Assisted Reproductive Technologies Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Assisted Reproductive Technologies Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Assisted Reproductive Technologies Drugs Overall Market Size
2.1 Global Assisted Reproductive Technologies Drugs Market Size: 2024 VS 2031
2.2 Global Assisted Reproductive Technologies Drugs Market Size, Prospects & Forecasts: 2020-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Assisted Reproductive Technologies Drugs Players in Global Market
3.2 Top Global Assisted Reproductive Technologies Drugs Companies Ranked by Revenue
3.3 Global Assisted Reproductive Technologies Drugs Revenue by Companies
3.4 Top 3 and Top 5 Assisted Reproductive Technologies Drugs Companies in Global Market, by Revenue in 2024
3.5 Global Companies Assisted Reproductive Technologies Drugs Product Type
3.6 Tier 1, Tier 2, and Tier 3 Assisted Reproductive Technologies Drugs Players in Global Market
3.6.1 List of Global Tier 1 Assisted Reproductive Technologies Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Assisted Reproductive Technologies Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Assisted Reproductive Technologies Drugs Market Size Markets, 2024 & 2031
4.1.2 Down-Regulation Drugs
4.1.3 Ovulation Stimulation Drugs
4.1.4 Ovulation Inducing Drugs
4.1.5 Luteal Support Medications
4.2 Segmentation by Type - Global Assisted Reproductive Technologies Drugs Revenue & Forecasts
4.2.1 Segmentation by Type - Global Assisted Reproductive Technologies Drugs Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Assisted Reproductive Technologies Drugs Revenue, 2026-2031
4.2.3 Segmentation by Type - Global Assisted Reproductive Technologies Drugs Revenue Market Share, 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Assisted Reproductive Technologies Drugs Market Size, 2024 & 2031
5.1.2 Hospital Pharmacy
5.1.3 Specialty & Retail Pharmacy
5.1.4 Online Pharmacy
5.2 Segmentation by Application - Global Assisted Reproductive Technologies Drugs Revenue & Forecasts
5.2.1 Segmentation by Application - Global Assisted Reproductive Technologies Drugs Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Assisted Reproductive Technologies Drugs Revenue, 2026-2031
5.2.3 Segmentation by Application - Global Assisted Reproductive Technologies Drugs Revenue Market Share, 2020-2031
6 Sights by Region
6.1 By Region - Global Assisted Reproductive Technologies Drugs Market Size, 2024 & 2031
6.2 By Region - Global Assisted Reproductive Technologies Drugs Revenue & Forecasts
6.2.1 By Region - Global Assisted Reproductive Technologies Drugs Revenue, 2020-2025
6.2.2 By Region - Global Assisted Reproductive Technologies Drugs Revenue, 2026-2031
6.2.3 By Region - Global Assisted Reproductive Technologies Drugs Revenue Market Share, 2020-2031
6.3 North America
6.3.1 By Country - North America Assisted Reproductive Technologies Drugs Revenue, 2020-2031
6.3.2 United States Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.3.3 Canada Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.3.4 Mexico Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.4 Europe
6.4.1 By Country - Europe Assisted Reproductive Technologies Drugs Revenue, 2020-2031
6.4.2 Germany Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.4.3 France Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.4.4 U.K. Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.4.5 Italy Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.4.6 Russia Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.4.7 Nordic Countries Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.4.8 Benelux Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.5 Asia
6.5.1 By Region - Asia Assisted Reproductive Technologies Drugs Revenue, 2020-2031
6.5.2 China Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.5.3 Japan Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.5.4 South Korea Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.5.5 Southeast Asia Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.5.6 India Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.6 South America
6.6.1 By Country - South America Assisted Reproductive Technologies Drugs Revenue, 2020-2031
6.6.2 Brazil Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.6.3 Argentina Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Assisted Reproductive Technologies Drugs Revenue, 2020-2031
6.7.2 Turkey Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.7.3 Israel Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.7.4 Saudi Arabia Assisted Reproductive Technologies Drugs Market Size, 2020-2031
6.7.5 UAE Assisted Reproductive Technologies Drugs Market Size, 2020-2031
7 Companies Profiles
7.1 Merck Serono
7.1.1 Merck Serono Corporate Summary
7.1.2 Merck Serono Business Overview
7.1.3 Merck Serono Assisted Reproductive Technologies Drugs Major Product Offerings
7.1.4 Merck Serono Assisted Reproductive Technologies Drugs Revenue in Global Market (2020-2025)
7.1.5 Merck Serono Key News & Latest Developments
7.2 Ipsen
7.2.1 Ipsen Corporate Summary
7.2.2 Ipsen Business Overview
7.2.3 Ipsen Assisted Reproductive Technologies Drugs Major Product Offerings
7.2.4 Ipsen Assisted Reproductive Technologies Drugs Revenue in Global Market (2020-2025)
7.2.5 Ipsen Key News & Latest Developments
7.3 Ferring
7.3.1 Ferring Corporate Summary
7.3.2 Ferring Business Overview
7.3.3 Ferring Assisted Reproductive Technologies Drugs Major Product Offerings
7.3.4 Ferring Assisted Reproductive Technologies Drugs Revenue in Global Market (2020-2025)
7.3.5 Ferring Key News & Latest Developments
7.4 Organon
7.4.1 Organon Corporate Summary
7.4.2 Organon Business Overview
7.4.3 Organon Assisted Reproductive Technologies Drugs Major Product Offerings
7.4.4 Organon Assisted Reproductive Technologies Drugs Revenue in Global Market (2020-2025)
7.4.5 Organon Key News & Latest Developments
7.5 Solvay
7.5.1 Solvay Corporate Summary
7.5.2 Solvay Business Overview
7.5.3 Solvay Assisted Reproductive Technologies Drugs Major Product Offerings
7.5.4 Solvay Assisted Reproductive Technologies Drugs Revenue in Global Market (2020-2025)
7.5.5 Solvay Key News & Latest Developments
7.6 Besins
7.6.1 Besins Corporate Summary
7.6.2 Besins Business Overview
7.6.3 Besins Assisted Reproductive Technologies Drugs Major Product Offerings
7.6.4 Besins Assisted Reproductive Technologies Drugs Revenue in Global Market (2020-2025)
7.6.5 Besins Key News & Latest Developments
7.7 Zhejiang Xianju
7.7.1 Zhejiang Xianju Corporate Summary
7.7.2 Zhejiang Xianju Business Overview
7.7.3 Zhejiang Xianju Assisted Reproductive Technologies Drugs Major Product Offerings
7.7.4 Zhejiang Xianju Assisted Reproductive Technologies Drugs Revenue in Global Market (2020-2025)
7.7.5 Zhejiang Xianju Key News & Latest Developments
7.8 Changchun GeneScience
7.8.1 Changchun GeneScience Corporate Summary
7.8.2 Changchun GeneScience Business Overview
7.8.3 Changchun GeneScience Assisted Reproductive Technologies Drugs Major Product Offerings
7.8.4 Changchun GeneScience Assisted Reproductive Technologies Drugs Revenue in Global Market (2020-2025)
7.8.5 Changchun GeneScience Key News & Latest Developments
7.9 Hybio Pharmaceutical
7.9.1 Hybio Pharmaceutical Corporate Summary
7.9.2 Hybio Pharmaceutical Business Overview
7.9.3 Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Major Product Offerings
7.9.4 Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Revenue in Global Market (2020-2025)
7.9.5 Hybio Pharmaceutical Key News & Latest Developments
7.10 Livzon Pharmaceutical
7.10.1 Livzon Pharmaceutical Corporate Summary
7.10.2 Livzon Pharmaceutical Business Overview
7.10.3 Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Major Product Offerings
7.10.4 Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Revenue in Global Market (2020-2025)
7.10.5 Livzon Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Assisted Reproductive Technologies Drugs Market Opportunities & Trends in Global Market
Table 2. Assisted Reproductive Technologies Drugs Market Drivers in Global Market
Table 3. Assisted Reproductive Technologies Drugs Market Restraints in Global Market
Table 4. Key Players of Assisted Reproductive Technologies Drugs in Global Market
Table 5. Top Assisted Reproductive Technologies Drugs Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Assisted Reproductive Technologies Drugs Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Assisted Reproductive Technologies Drugs Revenue Share by Companies, 2020-2025
Table 8. Global Companies Assisted Reproductive Technologies Drugs Product Type
Table 9. List of Global Tier 1 Assisted Reproductive Technologies Drugs Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Assisted Reproductive Technologies Drugs Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2024 & 2031
Table 12. Segmentation by Type - Global Assisted Reproductive Technologies Drugs Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Assisted Reproductive Technologies Drugs Revenue (US$, Mn), 2026-2031
Table 14. Segmentation by Application– Global Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2024 & 2031
Table 15. Segmentation by Application - Global Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2026-2031
Table 17. By Region– Global Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2024 & 2031
Table 18. By Region - Global Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2026-2031
Table 20. By Country - North America Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2026-2031
Table 22. By Country - Europe Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Asia Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2026-2031
Table 26. By Country - South America Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2026-2031
Table 28. By Country - Middle East & Africa Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2026-2031
Table 30. Merck Serono Corporate Summary
Table 31. Merck Serono Assisted Reproductive Technologies Drugs Product Offerings
Table 32. Merck Serono Assisted Reproductive Technologies Drugs Revenue (US$, Mn) & (2020-2025)
Table 33. Merck Serono Key News & Latest Developments
Table 34. Ipsen Corporate Summary
Table 35. Ipsen Assisted Reproductive Technologies Drugs Product Offerings
Table 36. Ipsen Assisted Reproductive Technologies Drugs Revenue (US$, Mn) & (2020-2025)
Table 37. Ipsen Key News & Latest Developments
Table 38. Ferring Corporate Summary
Table 39. Ferring Assisted Reproductive Technologies Drugs Product Offerings
Table 40. Ferring Assisted Reproductive Technologies Drugs Revenue (US$, Mn) & (2020-2025)
Table 41. Ferring Key News & Latest Developments
Table 42. Organon Corporate Summary
Table 43. Organon Assisted Reproductive Technologies Drugs Product Offerings
Table 44. Organon Assisted Reproductive Technologies Drugs Revenue (US$, Mn) & (2020-2025)
Table 45. Organon Key News & Latest Developments
Table 46. Solvay Corporate Summary
Table 47. Solvay Assisted Reproductive Technologies Drugs Product Offerings
Table 48. Solvay Assisted Reproductive Technologies Drugs Revenue (US$, Mn) & (2020-2025)
Table 49. Solvay Key News & Latest Developments
Table 50. Besins Corporate Summary
Table 51. Besins Assisted Reproductive Technologies Drugs Product Offerings
Table 52. Besins Assisted Reproductive Technologies Drugs Revenue (US$, Mn) & (2020-2025)
Table 53. Besins Key News & Latest Developments
Table 54. Zhejiang Xianju Corporate Summary
Table 55. Zhejiang Xianju Assisted Reproductive Technologies Drugs Product Offerings
Table 56. Zhejiang Xianju Assisted Reproductive Technologies Drugs Revenue (US$, Mn) & (2020-2025)
Table 57. Zhejiang Xianju Key News & Latest Developments
Table 58. Changchun GeneScience Corporate Summary
Table 59. Changchun GeneScience Assisted Reproductive Technologies Drugs Product Offerings
Table 60. Changchun GeneScience Assisted Reproductive Technologies Drugs Revenue (US$, Mn) & (2020-2025)
Table 61. Changchun GeneScience Key News & Latest Developments
Table 62. Hybio Pharmaceutical Corporate Summary
Table 63. Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Product Offerings
Table 64. Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Revenue (US$, Mn) & (2020-2025)
Table 65. Hybio Pharmaceutical Key News & Latest Developments
Table 66. Livzon Pharmaceutical Corporate Summary
Table 67. Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Product Offerings
Table 68. Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Revenue (US$, Mn) & (2020-2025)
Table 69. Livzon Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Assisted Reproductive Technologies Drugs Product Picture
Figure 2. Assisted Reproductive Technologies Drugs Segment by Type in 2024
Figure 3. Assisted Reproductive Technologies Drugs Segment by Application in 2024
Figure 4. Global Assisted Reproductive Technologies Drugs Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Assisted Reproductive Technologies Drugs Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Assisted Reproductive Technologies Drugs Revenue: 2020-2031 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Assisted Reproductive Technologies Drugs Revenue in 2024
Figure 9. Segmentation by Type – Global Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2024 & 2031
Figure 10. Segmentation by Type - Global Assisted Reproductive Technologies Drugs Revenue Market Share, 2020-2031
Figure 11. Segmentation by Application – Global Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2024 & 2031
Figure 12. Segmentation by Application - Global Assisted Reproductive Technologies Drugs Revenue Market Share, 2020-2031
Figure 13. By Region - Global Assisted Reproductive Technologies Drugs Revenue Market Share, 2020-2031
Figure 14. By Country - North America Assisted Reproductive Technologies Drugs Revenue Market Share, 2020-2031
Figure 15. United States Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 16. Canada Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 17. Mexico Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 18. By Country - Europe Assisted Reproductive Technologies Drugs Revenue Market Share, 2020-2031
Figure 19. Germany Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 20. France Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 21. U.K. Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 22. Italy Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 23. Russia Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 24. Nordic Countries Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 25. Benelux Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 26. By Region - Asia Assisted Reproductive Technologies Drugs Revenue Market Share, 2020-2031
Figure 27. China Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 28. Japan Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 29. South Korea Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 30. Southeast Asia Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 31. India Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 32. By Country - South America Assisted Reproductive Technologies Drugs Revenue Market Share, 2020-2031
Figure 33. Brazil Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 34. Argentina Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 35. By Country - Middle East & Africa Assisted Reproductive Technologies Drugs Revenue Market Share, 2020-2031
Figure 36. Turkey Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 37. Israel Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 38. Saudi Arabia Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 39. UAE Assisted Reproductive Technologies Drugs Revenue, (US$, Mn), 2020-2031
Figure 40. Merck Serono Assisted Reproductive Technologies Drugs Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Ipsen Assisted Reproductive Technologies Drugs Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Ferring Assisted Reproductive Technologies Drugs Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Organon Assisted Reproductive Technologies Drugs Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Solvay Assisted Reproductive Technologies Drugs Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Besins Assisted Reproductive Technologies Drugs Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Zhejiang Xianju Assisted Reproductive Technologies Drugs Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Changchun GeneScience Assisted Reproductive Technologies Drugs Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
